Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group
Synopsis: Christian Angermayer, a prominent investor and entrepreneur in the biotech industry, shares valuable insights in the Biotech2050 podcast, shedding light on the challenges and opportunities ...
7 Feb 202446min
Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT
Synopsis: In this episode of the Biotech2050 podcast, David Kirn, CEO of 4D Molecular Therapeutics, shares invaluable insights for aspiring entrepreneurs in the biotech industry. Kirn discusses the d...
31 Jan 202433min
Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics
Synopsis: In this episode of the Biotech2050 podcast, David Esposito, CEO of ONL Therapeutics, provides valuable insights into the challenges and opportunities in the field of ophthalmology. Esposito'...
10 Jan 202425min
Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics
Synopsis: In this episode of the Biotech2050 podcast, Jak Knowles, co-founder of Affini-T Therapeutics, shares valuable insights into the challenges faced by bootstrapped biotech companies and the si...
13 Des 202326min
A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology
Synopsis: Sean Bohen, M.D., Ph.D., is the President and CEO of Olema Oncology, a biopharmaceutical company developing innovative targeted therapies for women’s cancers. We’re excited to welcome Sean ...
6 Des 202320min
The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology
Synopsis: Troy Wilson, Ph.D., J.D., is the President and CEO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment o...
29 Nov 202333min
Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine
Synopsis: Keith Gottesdiener, MD, and Jeremy Duffield, MD, PhD, FRCP, are the President & CEO and CSO, respectively, of Prime Medicine. Prime Medicine was founded to bring the promise of gene editing...
22 Nov 202340min
Developing medicines for broad populations of cancer patients, Brett Hall, CSO, Immuneering
Synopsis: Brett Hall, Ph.D., is the CSO of Immuneering, a public, clinical-stage oncology company dedicated to developing medicines for broad populations of cancer patients by applying its deep knowl...
15 Nov 202341min
